P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 13.19 CNY -3.01% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Pulike Biological Engineering Inc?
Write Note

Pulike Biological Engineering Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pulike Biological Engineering Inc
Operating Expenses Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Operating Expenses
-ÂĄ550.5m
CAGR 3-Years
-7%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Expenses
-ÂĄ6.4B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Expenses
-ÂĄ1.3B
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
-17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Expenses
-ÂĄ15.6B
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
-15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Expenses
-ÂĄ6.5B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-12%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Expenses
-ÂĄ1.1B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pulike Biological Engineering Inc's Operating Expenses?
Operating Expenses
-550.5m CNY

Based on the financial report for Jun 30, 2024, Pulike Biological Engineering Inc's Operating Expenses amounts to -550.5m CNY.

What is Pulike Biological Engineering Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-12%

Over the last year, the Operating Expenses growth was 4%. The average annual Operating Expenses growth rates for Pulike Biological Engineering Inc have been -7% over the past three years , -12% over the past five years .

Back to Top